Novartis reimagines neurosciences by developing smart templates that measure progression in MS patients, in collaboration with FeetMe and the Vithas Nisa Foundation.
Recent News
Novartis and FeetMe partner to develop templates that measure the progression of multiple sclerosis
26 November 2018
FeetMe gets $2.3M for smart, connected insoles
05 October 2017
FeetMe, a medical device company that produces smart and connectedinsoles for improved running, walking and gait analysis, today announced it has raised € 1.95 million in seed funding.
The investment round was led by Kurma Diagnostics, with additional investment from the new Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV (a current shareholder of FeetMe).
